Professor Geoffrey Guy is the founder of GW Pharmaceuticals and served as Chairman from 1998 up to its sale to Jazz Pharmaceuticals in 2021. Prof. Guy is the creator of Sativex and Epidiolex and continues to lead innovation and new product discovery through active involvement in scientific innovation, medical research and global drug development for his entire career. Prior to his role at GW, Prof. Guy served as Chairman and Chief Executive of Ethical Holdings plc, a NASDAQ-quoted drug delivery Company (now Amarin Corporation plc, or Amarin), which he founded in 1985 and led to its NASDAQ listing in 1993. He founded Phytopharm plc in 1989, of which he was Chairman until 1997, and led to its London Stock Exchange listing in 1996. He is now the Founder and Chairman of The Guy Foundation, a U.K. charity which promotes and funds research into Quantum Biology and cellular bioenergetics.norary DSc from University of Reading 2016 for his contributions to science.

Geoffrey is the recipient of our ICRS Lifetime Achievement Award for 2023.